Kit Simpson to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Kit Simpson has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.060
-
Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remission. Clin Lymphoma Myeloma. 2008 Jun; 8(3):166-70.
Score: 0.060
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.